Overview

Lactoserum (Dermacyd Femina®) and Prevention of Recurrence of Bacterial Vaginosis

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate if the use of Dermacyd can avoid the recurrence of bacterial vaginosis after three months of the standard treatment.
Phase:
Phase 4
Details
Lead Sponsor:
Sanofi
Treatments:
Immune Sera